Management of vascular malformations and hemangiomas of the head and neck-an update

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 21, Issue 2, 2013, Pages 157-163

  Eivazi, Behfar ^a   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

arteriovenous malformations; capillary malformations; head and neck; hemangiomas; lymphatic malformations; vascular malformations; venous malformations

Indexed keywords

BLEOMYCIN; D DIMER; DOXYCYCLINE; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; ONYX COPOLYMER; PICIBANIL; PROPRANOLOL; SILDENAFIL; TIMOLOL;

ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; CAPILLARY HEMANGIOMA; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE SEVERITY; DRUG SAFETY; GOLD STANDARD; HEAD AND NECK MALFORMATION; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; LOW LEVEL LASER THERAPY; LUNG FUNCTION; NEODYMIUM YAG LASER; NEVUS FLAMMEUS; PRIORITY JOURNAL; PULSED DYE LASER; REVIEW; SCLEROTHERAPY; THROMBOCYTE AGGREGATION; VASCULITIS;

ADRENERGIC BETA-ANTAGONISTS; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; VASCULAR MALFORMATIONS;

EID: 84875425230     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32835e15a9     Document Type: Review

References (25)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Recons Surg 1982; 69:412-422.
2. Eivazi B, ArdeleanM, Bäumler W, et al. Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2009; 266:187-197.
3. Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg 2005; 32:99-116.
4. Eivazi B, Wiegand S, Negm H, et al. Orbital and periorbital vascular anomalies-an approach to diagnosis and therapeutic concepts. Acta Otolaryngol 2010; 130:942-951.
5. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358:2649-2651.
6. Eivazi B, Cremer HJ, Mangold C, et al. Hemangiomas of the nasal tip: an approach to a therapeutic challenge. Int J Pediatr Otorhinolaryngol 2011; 75:368-375.
7. Moehrle M, Léauté-Labrèze C, Schmidt V, et al. Topical timolol for small hemangiomas of infancy. Pediatr Dermatol 2012. doi: 10.1111/j.1525-1470.2012.01723.x. [Epub ahead of print]
8. Semkova K, Kazandjieva J. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study. Clin Exp Dermatol 2012. doi: 10.1111/j.1365-2230.2012.04425.x.
9. Faul JL, Berry GJ, Colby TV, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med 2000; 161:1037-1046.
10. Wiegand S, Eivazi B, Barth PJ, et al. Pathogenesis of lymphangiomas. Virch Arch 2008; 453:1-8.
11. Eivazi B, Teymoortash A, Wiegand S, et al. Intralesional endoscopy of advanced lymphatic malformations of the head and neck: a new diagnostic approach and a potential therapeutic tool. Arch Otolaryngol Head Neck Surg 2010; 136:790-795.
12. Reinglas J, Ramphal R, Bromwich M. The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 2011; 121:1851-1854.
13. Swetman GL, Berk DR, Vasanawala SS, et al. Sildenafil for severe lymphatic malformations. N Engl J Med 2012; 366:384-386.
14. Augustin M, Zschocke I, Wiek K, et al. Psychosocial stress of patients with port wine stains and expectations of dye laser treatment. Dermatology 1998; 197:353-360.
15. Hansen K, Kreiter CD, Rosenbaum M, et al. Long-term psychological impact and perceived efficacy of pulsed-dye laser therapy for patients with port-wine stains. Dermatol Surg 2003; 29:49-55.
16. Eivazi B, Roessler M, Pfützner W, et al. Port-wine stains are more than skin-deep! Expanding the spectrum of extracutaneous manifestations of nevi flammei of the head and neck. Eur J Dermatol 2012; 22:246-251.
17. Faurschou A, Olesen AB, Leonardi-Bee J, Haedersdal M. Lasers or light sources for treating port-wine stains. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD007152.
18. Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology 2010; 25:224-235.
19. Wiegand S, Eivazi B, Karger R, et al. Surgery in patients with vascular malformations of the head and neck: value of coagulation disorders. Phlebology 2009; 24:38-42.
20. Hou R, Guo J, Hu K, et al. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China. J Vasc Surg 2010; 51:940-945.
21. Sainsbury DC, Kessell G, Fall AJ, et al. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast Reconstr Surg 2011; 127:2031-2044.
22. Schumacher M, Dupuy P, Bartoli JM, et al. Treatment of venous malformations: first experience with a new sclerosing agent-a multicenter study. Eur J Radiol 2011; 80:e366-e372.
23. Dompmartin A, Blaizot X, Thé ron J, et al. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol 2011; 21:2647-2656.
24. Thiex R, Wu I, Mulliken JB, et al. Safety and clinical efficacy of Onyx for embolization of extracranial head and neck vascular anomalies. AJNR Am J Neuroradiol 2011; 32:1082-1086.
25. Burrows PE, Mulliken JB, Fishman SJ, et al. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child. J Craniofac Surg 2009; 20 (Suppl 1):597-602.